Clinical Trials Browser

Higher-risk Myelodysplastic Syndrome × Azacitidine × 1 year × Clear all

NCT06927232 2025-04-15

AZA+Lus VS AZA Monotherapy in HR-MDS

Phase 3 Not yet recruiting

Higher-risk Myelodysplastic Syndrome